Full CoverageFDA approves HIV drug based on University of Utah biochemist's findings
By Logan Stefanich
Top news
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
By Laura Santhanam
Regulators Approve a Twice-Yearly Shot to Prevent H.I.V. Infection
By Apoorva Mandavilli
FDA approves twice-a-year injection for HIV prevention
By Jacqueline Howard
HIV prevention drug hailed as a 'breakthrough' gets FDA approval : Goats and Soda
By Jonathan Lambert
Posts on X
Formerly Twitter
Gilead Sciences
GileadSciences
At Gilead, we're focused on delivering transformative therapies in #HIV and pushing the boundaries of scientific innovation in our mission to help end the epidemic. Here's what it takes. pic.x.com/r0rDCSjpjS
Posted on X
Unitaid
UNITAID
Unitaid is working with partners to make generic lenacapavir available quickly and affordably. Approvals mean little without access. Thanks @evolambert for an in-depth look at what’s needed next in @NPR’s excellent coverage.
Learn more: www.npr.org/sections/goats-and-soda/2025/06/18/g-s1-73130/hiv-prevention-drug-lenacapavir-fda-breakthrough
Posted on X
blkwomenshealth
blkwomenshealth
A breakthrough in HIV prevention! The FDA approved lenacapavir, and just 2 injections a year could provide near-complete protection from HIV. A game-changer for accessibility and reducing stigma. 🙌🏾
www.npr.org/sections/goats-and-soda/2025/06/18/g-s1-73130/hiv-prevention-drug-lenacapavir-fda-breakthrough pic.x.com/CKs4YAUeQw
Posted on X
W. Gyude Moore
gyude_moore
Regulators Approve Lenacapavir for H.I.V. Prevention - “The approval is among the most anticipated developments in the prevention of H.I.V. But it arrives during deep cuts to global health programs that were expected to purchase…in low-income countries.” www.nytimes.com/2025/06/18/health/hiv-fda-lenacapavir.html
Posted on X
All coverage
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it
By Lauran Neergaard
FDA approves first twice-yearly HIV prevention shot
By Jaleesa Irizarry
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
By Annika Kim Constantino
Here’s what everyone should know about this new HIV prevention shot
By Teddy Amenabar & Richard Sima
Aliveness Project to offer newly approved, first-of-its-kind HIV prevention treatment
By Samantha Fischer
Physician Views Preview: As Gilead 'PrEPs' for new era with Yeztugo, the focus turns to prescribers
By Jessica D'Amico
Cost Will Be Massive Barrier in Access to Lenacapavir After Approval in the US: Gordon Crofoot, MD, PA
By Julia Bonavitacola
FDA signs off on Gilead's landmark long-acting PrEP med, signaling new era in HIV prevention
By Zoey Becker
With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert
By Logan Lutton & Peter Wehrwein
FDA approves twice-yearly injectable for HIV prevention; local agency weighs in on impact in the Pine Belt
By Jay Harrison
Gilead Wins Historic Approval for Twice-Yearly HIV Drug
By Dan Samorodnitsky
FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.
By Josh Nathan-kazis
Gilead’s Twice-a-Year HIV Prevention Shot Wins FDA Approval
By Robert Langreth
Another tool in the fight against HIV — and more
By Lourdes Duarte, Patrick Elwood & Katharin Czink
FDA approves new HIV prevention drug
By Candice Bruce
US FDA approves Gilead's twice-yearly injection for HIV prevention
By Deena Beasley & Julie Steenhuysen
Groundbreaking twice-a-year HIV drug that could stop transmission approved
By Lauran Neergaard
FDA approves new twice-yearly HIV shot. What to know
By Ken Alltucker
FDA Approves “Breakthrough” HIV Drug
By Jackie Flynn Mogensen
HIV protection with just two shots a year: FDA approves Gilead drug
By Ed Silverman & Jason Mast